Literature DB >> 2897810

Altered hemodynamic response to dobutamine in relation to the degree of preoperative beta-adrenoceptor blockade.

J Tarnow1, K Komar.   

Abstract

The relationship between the extent of preoperative beta-adrenoceptor blockade and the hemodynamic properties of dobutamine was investigated in patients scheduled for elective myocardial revascularization during isoflurane-nitrous oxide anesthesia. Twenty patients had been treated with beta-adrenoceptor blocking drugs for at least 4 weeks before the study; 11 unblocked patients served as control group. The extent of clinical beta-adrenoceptor blockade was quantified using the isoproterenol sensitivity test. The dose of isoproterenol required to increase heart rate by 25 beats/min was defined as the CD25 (chronotropic dose 25), representing the degree of beta-adrenoceptor blockade. Geometric mean CD25/70 kg was 3.8 micrograms in the control group, and 24.5 micrograms in the patients receiving beta-adrenoceptor blocking drugs. The authors found a significant inverse relationship between CD25 values and changes in cardiac index in response to three dobutamine infusion rates (1.0, 2.0, and 4.0 micrograms.kg-1.min-1), the correlation coefficients being -0.78, -0.79, and -0.82, respectively. Compared to unblocked patients, almost no change, or even a decrease, of the cardiac index was observed at higher degrees of clinical beta-adrenoceptor blockade. Moreover, there was a significant linear correlation (r = 0.66 - 0.75) between CD25 values and the effects of dobutamine on systemic vascular resistance index (SVRI), i.e., SVRI decreased in control patients, but increased in patients with high degrees of preoperative beta-adrenoceptor blockade. This unmasked vasocontrictive response to dobutamine was observed despite the fact that the majority of our patients had received cardioselective adrenergic blocking drugs.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2897810     DOI: 10.1097/00000542-198806000-00013

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  5 in total

1.  Use of ivabradine in catecholamine-induced tachycardia after high-risk cardiac surgery.

Authors:  Domenico Vitale; Vincenzo De Santis; Fabio Guarracino; Andrea Fontana; Fabio Pellegrini; Luigi Tritapepe
Journal:  Clin Res Cardiol       Date:  2010-09-07       Impact factor: 5.460

2.  An echocardiographic study of interactions between pindolol and epinephrine contained in a local anesthetic solution.

Authors:  M Sugimura; Y Hirota; T Shibutani; H Niwa; T Hori; Y Kim; H Matsuura
Journal:  Anesth Prog       Date:  1995

Review 3.  Novel drugs for heart rate control in heart failure.

Authors:  Agata Bielecka-Dabrowa; Stephan von Haehling; Jacek Rysz; Maciej Banach
Journal:  Heart Fail Rev       Date:  2018-07       Impact factor: 4.214

Review 4.  Ivabradine: potential clinical applications in critically ill patients.

Authors:  Vincenzo De Santis; Domenico Vitale; Anna Santoro; Aurora Magliocca; Andrea Giuseppe Porto; Cecilia Nencini; Luigi Tritapepe
Journal:  Clin Res Cardiol       Date:  2012-10-14       Impact factor: 5.460

5.  Different responses to dobutamine in the presence of carvedilol or metoprolol in patients with chronic heart failure.

Authors:  E Bollano; M Scharin Täng; A Hjalmarson; F Waagstein; B Andersson
Journal:  Heart       Date:  2003-06       Impact factor: 5.994

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.